PURPOSE: We examined 14 d of oral adenosine 5'-triphosphate (ATP) supplementation on indices of anaerobic capacity and muscular strength. METHODS:Twenty-seven healthy males successfully completed the trial, after randomly receiving in a double-blind manner an oral dose of low dose (150 mg) or high dose (225 mg) ATP, or matched placebo. To improve absorption characteristics, the ATP was enterically coated. Total blood ATP (whole blood and plasma ATP) concentrations, two Wingate anaerobic power tests (30 s), and muscular strength (1RM and three sets of repetitions to fatigue at 70% of 1RM) were measured under three conditions: (i) baseline; (ii) acutely (7d later, no prior supplementation and 75 min after ATP ingestion); and (iii) after 14 d of daily ingestion (post). RESULTS: Statistical analyses showed no significant between or within group treatment effects for whole blood ATP or plasma ATP concentrations for any treatment condition. We also did not observe any treatment effects for any Wingate testing parameter including peak PO, total work, average PO for 30 s, or post-Wingate lactate accumulation. Overall, we observed no significant between group treatment effects for any muscular strength parameter. We did observe several within group differences for the group ingesting the high ATP dosage including 1RM (6.6%; P < 0.04) and repetitions to fatigue during set 1 of posttesting (18.5%; P < 0.007) and total lifting volume at post (22%; P < 0.003). CONCLUSIONS: We conclude that enterically coated oral ATP supplementation may provide small ergogenic effects on muscular strength under some treatment conditions.
RCT Entities:
PURPOSE: We examined 14 d of oral adenosine 5'-triphosphate (ATP) supplementation on indices of anaerobic capacity and muscular strength. METHODS: Twenty-seven healthy males successfully completed the trial, after randomly receiving in a double-blind manner an oral dose of low dose (150 mg) or high dose (225 mg) ATP, or matched placebo. To improve absorption characteristics, the ATP was enterically coated. Total blood ATP (whole blood and plasma ATP) concentrations, two Wingate anaerobic power tests (30 s), and muscular strength (1RM and three sets of repetitions to fatigue at 70% of 1RM) were measured under three conditions: (i) baseline; (ii) acutely (7d later, no prior supplementation and 75 min after ATP ingestion); and (iii) after 14 d of daily ingestion (post). RESULTS: Statistical analyses showed no significant between or within group treatment effects for whole blood ATP or plasma ATP concentrations for any treatment condition. We also did not observe any treatment effects for any Wingate testing parameter including peak PO, total work, average PO for 30 s, or post-Wingate lactate accumulation. Overall, we observed no significant between group treatment effects for any muscular strength parameter. We did observe several within group differences for the group ingesting the high ATP dosage including 1RM (6.6%; P < 0.04) and repetitions to fatigue during set 1 of posttesting (18.5%; P < 0.007) and total lifting volume at post (22%; P < 0.003). CONCLUSIONS: We conclude that enterically coated oral ATP supplementation may provide small ergogenic effects on muscular strength under some treatment conditions.
Authors: Edward H Abraham; Guido Guidotti; Eliezer Rapaport; David Bower; Jack Brown; Robert J Griffin; Andrew Donnelly; Ellen D Waitzkin; Kenon Qamar; Mark A Thompson; Sukumar Ethirajan; Kent Robinson Journal: Purinergic Signal Date: 2021-05-10 Impact factor: 3.765
Authors: Jacob M Wilson; Jordan M Joy; Ryan P Lowery; Michael D Roberts; Christopher M Lockwood; Anssi H Manninen; John C Fuller; Eduardo O De Souza; Shawn M Baier; Stephanie Mc Wilson; John A Rathmacher Journal: Nutr Metab (Lond) Date: 2013-09-22 Impact factor: 4.169
Authors: Jordan M Joy; Roxanne M Vogel; Jordan R Moon; Paul H Falcone; Matt M Mosman; Zbigniew Pietrzkowski; Tania Reyes; Michael P Kim Journal: BMC Complement Altern Med Date: 2016-07-18 Impact factor: 3.659
Authors: John A Rathmacher; John C Fuller; Shawn M Baier; Naji N Abumrad; Hector F Angus; Rick L Sharp Journal: J Int Soc Sports Nutr Date: 2012-10-09 Impact factor: 5.150
Authors: Ralf Jäger; Michael D Roberts; Ryan P Lowery; Jordan M Joy; Clayton L Cruthirds; Christopher M Lockwood; John A Rathmacher; Martin Purpura; Jacob M Wilson Journal: J Int Soc Sports Nutr Date: 2014-06-13 Impact factor: 5.150
Authors: Jordan M Joy; Roxanne M Vogel; Jordan R Moon; Paul H Falcone; Matt M Mosman; Michael P Kim Journal: J Int Soc Sports Nutr Date: 2016-06-10 Impact factor: 5.150